Sinocare Showcased Diabetes Tools at EASD Meeting
The company demonstrated its latest glucose monitoring and analyzer technology at the recent conference in Milan.
Updated on Sept. 30, 2026 in Diabetes
Live Poll
Do you believe digital monitoring tools improve your ability to manage your chronic health conditions?
Sinocare presented its latest portfolio of chronic disease management solutions at the 62nd Annual Meeting of the European Association for the Study of Diabetes. The exhibition featured advanced diagnostic tools designed to streamline glucose monitoring and multi-parameter analysis for patients worldwide.
Why it matters
As global demand for accessible diagnostic technology grows, companies like Sinocare are expanding their footprint by integrating biosensing hardware with digital health platforms. These developments aim to provide more efficient, data-driven health management for the millions of individuals currently managing chronic conditions.
The Safe AQ max II system delivers glucose results in five seconds, while the iCARE-1300 analyzer provides testing across nearly 100 parameters in 3 to 15 minutes. Sinocare currently holds more than 780 patents and maintains nine R&D and manufacturing sites.
The players
Sinocare
This global company specializes in the development and manufacturing of biosensing technologies and integrated healthcare solutions.
European Association for the Study of Diabetes
This international organization facilitates scientific research and professional exchange regarding the causes and management of diabetes.
The details
Sinocare demonstrated the Safe AQ 8000 system, which bridges blood glucose meters and continuous glucose monitor data via a specialized web portal. Additionally, the company highlighted the AGEscan detector, a device capable of non-invasive detection of Advanced Glycation End Products, further expanding their diagnostic capabilities.
Timeline
Sinocare was established in 2002.
The 62nd Annual Meeting of the European Association for the Study of Diabetes began in Milan on September 28, 2026.
The company showcase took place during the conference, which concludes on October 2, 2026.
The Big Picture
The Sinocare showcase follows the established tradition of diagnostic technology updates typically unveiled at the European Association for the Study of Diabetes Annual Meeting. The company used the platform of this international medical conference to highlight its latest advancements in biosensing and patient monitoring.
These diagnostic systems offer patients faster results and more seamless data integration between home testing devices and medical portals. Such improvements facilitate more efficient communication with healthcare providers, potentially reducing the administrative burden of chronic disease management.
The takeaway
The integration of non-invasive detection methods and multi-parameter analysis represents a shift toward more comprehensive, real-time health monitoring. Readers should prioritize discussing these emerging diagnostic capabilities with their clinicians to determine if new monitoring tools might improve their current treatment plans.
Further reading
Learn more about the latest innovations in Diabetes management.
More information
For more details on the showcased technologies, visit Sinocare official company information.
Live Poll
Do you believe digital monitoring tools improve your ability to manage your chronic health conditions?
